GPC3 and hepatocellular carcinoma: Hamoaka et al. established that elevated glypican-3-positive circulating tumor cells, identified by liquid biopsy in hepatocellular carcinoma patients prior to hepatectomy, correlate with microscopic portal vein invasion (mPVI) [8].